AccessibilityHelp

Most Active Stocks Daily Stock Gainers Daily Stock Losers

Most Active Stocks Daily Stock Gainers Daily Stock Losers

Maxx Chatsko

XMFBlacknGoldX

Maxx has been a contributor to Fool.com since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.

Articles by Maxx Chatsko — Page 97

058 fdecomite flickr

Aug 9, 2016 by Maxx Chatsko

TerraVia Announces Lackluster Earnings, But Can a New CEO Reignite Growth?

The growth, or lack of it, sent shares tanking the day after the earnings call, but that's to be expected for a company in transition. Now investors will be looking to the new CEO to deliver investors to the promised land.

058 chris potter flickr

Aug 2, 2016 by Maxx Chatsko

This Under-the-Radar Stock Powers the Pharma Industry -- and It Just Raised 2016 Guidance

Cambrex Corporation manufactures active pharmaceutical ingredients for dozens of therapeutics used everyday. You could say it’s having a pretty good run.

054 tva flickr

Jul 23, 2016 by Maxx Chatsko

Are General Electric's Nuclear Ambitions Doomed?

The company has long supported nuclear energy and is making big bets on next-generation reactors, but backlash against atomic power and a lost opportunity in the United Kingdom may stall development efforts.

047 dna-genetics-science-biology_large

Jul 21, 2016 by Maxx Chatsko

Here's Why Myriad Genetics Is Down 26% in 2016

A combination of disappointing guidance and increasing competition has resulted in a painful 2016 for Myriad Genetics investors, but there are reasons for optimism.

040 Piracicaba First Release Van Mosquitos Being Released Detail

Jul 21, 2016 by Maxx Chatsko

Intrexon's Genetically Engineered Mosquitoes (Finally) Have Data. What's Next?

A complete absence of data showing the potential of genetically engineered mosquitoes to benefit public health is no longer the case. However, it may take a few more years before Intrexon investors see significant contributions to the top and bottom line.

046 braskem green pe

Jul 20, 2016 by Maxx Chatsko

Here's My Top Stock to Buy in July

The world will turn its attention to Brazil next month as it hosts the Olympics. Bargain-hunting investors may want to do the same.

042 _DSC9354

Jul 15, 2016 by Maxx Chatsko

Sugary Soft Drinks Are Dead, But Coca-Cola's Future is Sweet

Carbonated soft drink sales have fallen for 11 straight years as consumers make healthier choices. But don’t write-off soda just yet -- innovative ingredients could lead to a bright future.

048 umberto salvagnin flickr

Jul 13, 2016 by Maxx Chatsko

This Farming Tool Is Failing. Can Intrexon Bail Out an Industry?

Agricultural technology companies have had few answers to insects resistant to Bacillus thuringiensis, which threatens a sharp increase in insecticide use without effective solutions.

049 united soybean board flickr

Jul 11, 2016 by Maxx Chatsko

This Is Why Bunge Limited Shares Dropped 12.4% in June

The agricultural-products powerhouse is also prone to being knocked around by volatile oil prices, but a major debt offering eroded investor confidence, as well.

050 steve jurvetson flickr

Jul 11, 2016 by Maxx Chatsko

Pacific Ethanol Slid 15.8% in June -- but It Could Have Been Worse

The ethanol leader had a depressing month, but shares are still up considerably this year.

052 kodak achieve platesetter

Jul 11, 2016 by Maxx Chatsko

Comeback Kid: Eastman Kodak Shares Popped 20% in June

The company has now gained 32% year to date as investors bet on streamlined operations returning to profitability.

051 cl baker flickr

Jul 11, 2016 by Maxx Chatsko

Here's Why Huntsman Corporation Shares Fell 12% in June

Shares gave back all of the gains made since the beginning of April in just a few short days of knee-jerk reactions.

053 united soybean board flickr

Jul 11, 2016 by Maxx Chatsko

These Nitrogen Fertilizer Stocks Dropped Over 10% in June

Investors were spooked about rising input costs and falling selling prices, but futures contracts could insulate producers for a few quarters.

047 dna-genetics-science-biology_large

Jul 6, 2016 by Maxx Chatsko

Intrexon Just Diluted Ziopharm Investors Big Time

The new deal has direct and indirect implications for both companies' investors.

nuclear cooling towers

Jul 2, 2016 by Maxx Chatsko

Illinois Doesn't Value Exelon's Nuclear Power -- and That's a Huge Climate Mistake

The two nuclear facilities being closed generate more than twice the carbon-free electricity as all the state's wind and solar power combined. Still want to close them?

042 decar66 flickr

Jul 1, 2016 by Maxx Chatsko

Does This Intrexon Opportunity Dwarf Zika Virus?

The company's tool for controlling the spread of Zika virus and other mosquito-borne illnesses may get all of the press, but it may not be the most financially important product for investors.

GettyImages-511204604

Jun 28, 2016 by Maxx Chatsko

Intrexon and Zika Virus: An Interview With Oxitec's Hadyn Parry

A new tool for combating mosquito-borne illnesses targets the source with unparalleled accuracy. Oxitec CEO Hadyn Parry talks about pioneering self-limiting mosquitoes.

045 farbenfrohewunderwelt flickr

Jun 28, 2016 by Maxx Chatsko

Think We Can Abandon Nuclear Energy? Don't Look at This Chart.

Twelve nuclear reactors have been shuttered or given a future expiration date since 2013. That's horrible news for our ability to act on climate change.

039 alejandra pales flickr

Jun 27, 2016 by Maxx Chatsko

The $100 Million Platform Intrexon Investors Forgot

Investors seem fixated on the company's Zika virus tools and healthcare pipeline, but there's a sweet opportunity with near-term revenue potential going unnoticed.

fish farm

Jun 24, 2016 by Maxx Chatsko

3 Stocks Investing in This Under-the-Radar Growth Opportunity

It's a fish-eat-fish world out there, but these companies are looking to change that with new products that can support long-term growth.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services